Hematology and Oncology
Home Hematology and Oncology
Radical Hemithoracic Radiation Tx Ups Survival in Mesothelioma
Higher overall survival seen at two years in patients with malignant pleural mesothelioma
Radiotherapy Tied to Lower Recurrence of Early, Hormone-Driven Breast Cancer
Antihormone treatment also recommended in conjunction with radiotherapy
EPA Says Weed Killer in Roundup Is Safe
EPA states that glyphosate 'is not likely to be carcinogenic to humans'
Combo Nicotine Replacement Tx Ups Success in Quitting Smoking
Higher doses of nicotine gum and patches also may increase quit rate
Postchemo Radiation Tx May Benefit Some With Hodgkin Lymphoma
Survival benefit seen for radiotherapy after ABVD regimen, but difference not statistically significant
Targeted Therapy Promising for Rare Hematologic Cancer
Tagraxofusp seems effective for treating blastic plasmacytoid dendritic-cell neoplasm
Single-Dose Brachytherapy Effective for Prostate Cancer
Two-year and three-year biochemical progression-free survival rate of 100 percent for low-risk disease
Telerehabilitation Aids Function, Pain With Advanced Cancer
But the addition of pharmacological pain management did not offer further benefit
Gender Differences Seen in Adverse Drug Reactions
Differences found in reaction symptoms and types of drugs tied to adverse reactions
Improvement Needed in Doctor-Patient Lung Cancer Screening Discussions
Crude estimated rates of physician-patient discussion dropped from 6.7 to 4.3 percent in 2012 to 2017
